| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 58.85B | 53.66B | 54.04B | 55.55B | 63.49B |
| Gross Profit | 15.60B | 30.28B | 32.40B | 34.27B | 44.93B |
| EBITDA | 22.31B | 23.16B | 21.08B | 25.54B | 36.13B |
| Net Income | 10.18B | 11.55B | 10.06B | 12.39B | 21.11B |
Balance Sheet | |||||
| Total Assets | 128.15B | 102.79B | 103.55B | 96.74B | 102.90B |
| Cash, Cash Equivalents and Short-Term Investments | 9.45B | 7.20B | 9.78B | 8.94B | 15.35B |
| Total Debt | 24.59B | 13.86B | 14.35B | 12.27B | 13.53B |
| Total Liabilities | 61.10B | 44.82B | 47.21B | 44.47B | 46.31B |
| Stockholders Equity | 62.23B | 55.25B | 54.59B | 50.17B | 51.43B |
Cash Flow | |||||
| Free Cash Flow | 4.91B | 5.98B | 8.07B | 9.38B | 17.96B |
| Operating Cash Flow | 17.51B | 15.60B | 15.16B | 16.13B | 25.34B |
| Investing Cash Flow | -18.08B | -9.59B | -6.96B | -6.71B | -7.16B |
| Financing Cash Flow | 864.77M | -7.09B | -5.28B | -15.47B | -15.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £136.21B | 6.00 | 16.59% | 4.75% | 4.05% | -16.51% | |
65 Neutral | £561.56M | 11.82 | 4.19% | ― | -1.71% | 94.27% | |
63 Neutral | £42.07B | -6.53 | -20.10% | 0.80% | -34.37% | -23.82% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | £67.07B | 16.06 | 0.96% | 1.89% | 3.75% | ― | |
52 Neutral | £205.17M | -0.32 | -34.92% | 7.30% | -22.99% | -583.84% |